Household products company Reynolds (NASDAQ:REYN) announced better-than-expected revenue in Q4 CY2025, with sales up 1.3% year on year to $1.03 billion. On the other hand, next quarter’s revenue guidance of $809.8 million was less impressive, coming in 3.

Building operations company Johnson Controls (NYSE:JCI) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.8% year on year to $5.80 billion. Its non-GAAP profit of $0.89 per share was 5.7% above analysts’ consensus esti

Ride sharing and on-demand delivery platform Uber (NYSE:UBER) met Wall Streets revenue expectations in Q4 CY2025, with sales up 20.1% year on year to $14.37 billion. Its non-GAAP profit of $0.71 per share was 11% below analysts’ consensus estimates.

European and U.S. software stocks struggled to find support on Wednesday as a sector-wide selloff spread to Asia, fuelled by mounting worries that advances in artificial intelligence could upend companies' business ​models. European data analytics, profe

Constellation Energy has lagged behind the broader market over the past year, yet analysts remain moderately optimistic about the stock’s growth prospects.

With Applied Materialsignificantly outperforming the broader market over the past year, Wall Street analysts remain moderately bullish, reflecting confidence in the company’s positioning within the AI-driven semiconductor investment cycle.

Dubbed as the “fast entry” rule, the planned revision would allow a new listing to join the Nasdaq 100 after the first 15 trading days, Nasdaq said in a statement. Among companies expected to make initial public offerings this year is SpaceX, whose poten

PPL Corporation has lagged the broader market over the past year, prompting analysts to strike a cautiously optimistic tone about its future growth prospects.

The appointment of Lauren Weinberg to the top marketing post comes on the heels of Melis del Rey becoming CEO at the end of 2025.

Despite Tyson Foods slightly lagging the broader market over the past year, Wall Street analysts remain cautiously optimistic on its future potential.

Target has lagged the broader market over the past year, prompting Wall Street analysts to adopt a cautious stance on its future outlook.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 42.6% year on year to $19.29 billion. The company’s full-year revenue guidance of $81.5 billion at the midpoint came i

Despite trailing the S&P 500 Index over the past year, Visa continues to command strong confidence on Wall Street.

Shares tumbled after the company predicted a 5–13% decline in 2026 sales and operating profit, citing lower US prices and rising competition.View on euronews

Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 per share was 5.8% above analysts’ consensus estimates.